Hepatitis E virus and renal transplantation

Hepatitis Monthly

Volumn 11, Issue 8, 2011, Pages 599-600

  Moghaddam, Seyed Mohammadmehdi Hosseini ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hepatitis E virus; Renal transplantation

Indexed keywords

CREATININE; IMMUNOGLOBULIN G ANTIBODY; LIVER ENZYME; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; TACROLIMUS;

CHRONIC HEPATITIS; CHRONICITY; CONVALESCENCE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; EDITORIAL; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPETENCE; KIDNEY TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; RISK FACTOR; SCREENING TEST; SEROPREVALENCE; SOCIAL STATUS; THROMBOCYTE COUNT; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 80052563322     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.770     Document Type: Editorial

References (26)

1. Sepehrvand N, Khameneh ZR, Masudi S. Seroprevalence of Hepatitis E among Iranian Renal Transplant Recipients. Hepat Mon. 2011;11(8):[Epub a head of print].
2. Chandra V, Taneja S, Kalia M, Jameel S. Molecular biology and pathogenesis of hepatitis E virus. J Biosci. 2008;33(4):451-64.
3. Ghorbani GA, Alavian SM, Esfahani AA, Assari S. Seroepidemiology of hepatitis E virus in Iranian soldiers. Hepat Mon. 2007;7(3):121-4.
4. Somi MH, Farhang S, Majidi G, Shavakhi A, Pouri AA. Seroprevalence of hepatitis E in patients with chronic liver disease from East Azerbaijan, Iran. Hepat Mon. 2007;7(3):125-8.
5. Pourahmad M, Sotoodeh A, Nasiri H. Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Jahrom, Southern Iran. Hepat Mon. 2009;9(3):232-5.
6. Alavian SM. Hepatitis E Virus Infection: A Neglected Problem in Our Region. Hepat Mon. 2007;7(3):119-21.
7. Shamsizadeh A, Nikfar R, Makvandi M, Shamsizadeh N. Seroprevalence of Hepatitis E Virus Infection in Children in the Southwest of Iran. Hepat Mon. 2009;9(4):261-4.
8. Amarapurkar D, Agal S, Baijal R, Gupte P, Patel N, Kamani P, et al. Epidemiology of Hepatitis E Virus Infection in Western India. Hepat Mon. 2008;8(4):258-62.
9. Pavio N, Mansuy JM. Hepatitis E in high-income countries. Curr Opin Infect Dis. 2010;23(5):521-7.
10. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811-7.
11. Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol. 2010;31(5):398-407.
12. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150(6):430.
13. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025-7.
14. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140(5):1481-9.
15. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation. 2010;89(3):353-60.
16. Kamar N, Mansuy JM, Esposito L, Legrand-Abravanel F, Peron JM, Durand D, et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am J Kidney Dis. 2005;45(1):193-6.
17. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E Virus Related Cirrhosis in Kidney and Kidney-Pancreas Transplant Recipients. Am J Transplant. 2008;8(8):1744-8.
18. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Kruger DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol. 2011;[Epub ahead of print].
19. Pischke S, Wedemeyer H. Chronic hepatitis E in liver transplant recipients: a significant clinical problem? Minerva Gastroenterol Dietol. 2010;56(2):121-8.
20. Tavitian S, Peron JM, Huynh A, Mansuy JM, Ysebaert L, Huguet F, et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol. 2010;49(2):141-4.
21. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008;358(8):859-60.
22. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl. 2010;16(4):474-7.
23. Kamar N, Abravanel F, Garrouste C, Cardeau-Desangles I, Mansuy JM, Weclawiak H, et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant. 2010;25(8):2792-5.
24. Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tesse S, Thervet E, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med. 2010;153(2):85-9.
25. Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant. 2011;30(7):841-3.
26. Kamar N, Izopet J, Cintas P, Garrouste C, Uro-Coste E, Cointault O, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant. 2010;10(5):1321-4.